Why is BIOTON SA ?
- Poor long term growth as Net Sales has grown by an annual rate of 3.73% and Operating profit at -12.79% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 0.91 times
- OPERATING CASH FLOW(Y) Lowest at PLN 10.41 MM
- PRE-TAX PROFIT(Q) At PLN -5.12 MM has Fallen at -354.23%
- NET PROFIT(Q) At PLN -5.15 MM has Fallen at -680.73%
- Along with generating -8.41% returns in the last 1 year, the stock has also underperformed Poland WIG in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BIOTON SA for you?
Low Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 0.69%
Fallen by -44.46% (YoY
Higher at PLN 0.96 MM
Lowest at PLN 10.41 MM
At PLN -5.12 MM has Fallen at -354.23%
At PLN -5.15 MM has Fallen at -680.73%
At PLN 1.52 MM has Grown at 64.11%
Lowest at 69.7
Lowest at PLN 49.12 MM
Lowest at PLN 1.06 MM
Lowest at 2.15 %
Here's what is working for BIOTON SA
Raw Material Cost as a percentage of Sales
Here's what is not working for BIOTON SA
Net Sales (PLN MM)
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
Operating Cash Flows (PLN MM)
Interest Paid (PLN MM)
Operating Profit to Interest
Net Sales (PLN MM)
Operating Profit (PLN MM)
Operating Profit to Sales






